These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two support the concept of targeting ACKR3 as a novel method to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant disorders. In addition to the explained above https://friedrichq737kau4.bloginder.com/profile